KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in KalVista Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- −10 vs. Q1 2024
- Shares held
- 48.2M
- +1.25M (+2.7%) vs. Q1 2024
- Total value
- $568.2M
- +$11.0M (+2.0%) vs. Q1 2024
- New holders
- 19
- 45 more added
- Sold out
- 29
- 33 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $189 |
| Q1 2026 | 184 | $1.39B |
| Q4 2025 | 162 | $1.08B |
| Q3 2025 | 145 | $714.0M |
| Q2 2025 | 140 | $615.5M |
| Q1 2025 | 128 | $633.7M |
| Q4 2024 | 130 | $467.4M |
| Q3 2024 | 122 | $561.0M |
| Q2 2024 | 119 | $568.2M |
| Q1 2024 | 129 | $557.2M |
| Q4 2023 | 93 | $453.0M |
| Q3 2023 | 101 | $349.2M |
| Q2 2023 | 94 | $310.1M |
| Q1 2023 | 88 | $265.0M |
| Q4 2022 | 91 | $236.2M |
| Q3 2022 | 94 | $372.0M |
| Q2 2022 | 91 | $238.7M |
| Q1 2022 | 89 | $363.9M |
| Q4 2021 | 97 | $314.6M |
| Q3 2021 | 105 | $408.2M |
| Q2 2021 | 110 | $582.7M |
| Q1 2021 | 117 | $605.1M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Emerald Advisers, LLC | 643,897 | $7.59M | 0.32% | −27,279−4.1% | Reduced |
| StemPoint Capital LP | 736,765 | $8.68M | 2.55% | −424,295−36.5% | Reduced |
| State Street Corp | 756,430 | $8.91M | 0.00% | +162,257+27.3% | Added |
| Geode Capital Management, LLC | 806,271 | $9.50M | 0.00% | +154,383+23.7% | Added |
| DAFNA Capital Management LLC | 806,973 | $9.51M | 2.27% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 881,937 | $10.4M | 1.61% | +121,215+15.9% | Added |
| First Turn Management, LLC | 1,059,540 | $12.5M | 2.03% | −119,880−10.2% | Reduced |
| Saturn V Capital Management LLC | 1,128,478 | $13.3M | 5.02% | −313,474−21.7% | Reduced |
| Great Point Partners LLC | 1,338,568 | $15.8M | 3.02% | +1,338,568 | New |
| Boxer Capital, LLC | 1,590,000 | $18.7M | 0.99% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,990,588 | $23.4M | 0.00% | +305,475+18.1% | Added |
| Adage Capital Partners GP, L.L.C. | 2,050,000 | $24.1M | 0.04% | −525,000−20.4% | Reduced |
| Vestal Point Capital, LP | 2,300,000 | $27.1M | 2.02% | +1,645,000+251.1% | Added |
| BlackRock Inc. | 2,945,116 | $34.7M | 0.00% | +512,882+21.1% | Added |
| Capital World Investors | 3,227,620 | $38.0M | 0.01% | +1,763,014+120.4% | Added |
| Frazier Life Sciences Management, L.P. | 3,687,867 | $43.4M | 2.03% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 4,192,005 | $49.4M | 2.02% | 00.0% | Unchanged |
| Tang Capital Management LLC | 4,218,829 | $49.7M | 5.06% | +93,484+2.3% | Added |
| VR Adviser, LLC | 6,249,731 | $73.6M | 4.69% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −1,163,356−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −386,000−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −243,484−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −120,308−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −55,444−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −41,951−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −32,025−100.0% | Sold out |
| Lincoln National Corp | 0 | $0 | 0.00% | −20,660−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −20,615−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,329−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −15,431−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −14,467−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,800−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −12,082−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −10,538−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −10,234−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −10,172−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −3,600−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,820−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −414−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −81−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | 0 | Sold out |